Trials / Conditions / Pulmonary Vein Isolation

Pulmonary Vein Isolation

13 registered clinical trials studyying Pulmonary Vein Isolation — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation NCT07471308	CathVision ApS	—
Not Yet Recruiting	Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Hea NCT06969378	Boston Children's Hospital	N/A
Recruiting	Impact of Atrial Fibrillation Ablation on Sleep Parameters. NCT07259200	Primula Clinics	—
Completed	PulseSelect Based Pulmonary Vein Isolation and Ablation in Patients With Atrial Fibrillation NCT07035288	Tsiachris Dimitrios	N/A
Active Not Recruiting	Impact of Catheter Stability on the Outcomes With Very High Power Short Duration Ablation NCT06721221	Semmelweis University	N/A
Completed	Lesion Characteristics After Pulsed-Field Ablation in Patients With Atrial Fibrillation and a Left Common Osti NCT05812261	Onze Lieve Vrouwe Gasthuis	—
Completed	CLOSE Versus High Density Mapping Guided Catheter Ablation of Paroxysmal Atrial Fibrillation NCT04466358	University Medical Centre Ljubljana	N/A
Active Not Recruiting	Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial NCT04405258	Institute for Clinical Effectiveness, Japan	Phase 4
Completed	'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF NCT04041778	University of Leicester	—
Unknown	Wide Area Circumferential Ablation With Contact Force Versus Cryoballoon Ablation NCT03564925	The Second Affiliated Hospital of Chongqing Medical University	N/A
Completed	The Comparison Between the PVAM and CPVI for the Patients of PAF NCT03026413	The First Affiliated Hospital with Nanjing Medical University	N/A
Completed	Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data NCT01730924	Queen Mary University of London	N/A
Completed	ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial NCT01058980	Montreal Heart Institute	Phase 4